Iterum Therapeutics Revenue

Iterum Therapeutics had revenue of $390.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $390.00K.

Revenue (ttm)

390.00K

Revenue Growth

n/a

P/S Ratio

2.52

Revenue / Employee

43.33K

Employees

Market Cap

982.74K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
LakeShore Biopharma	84.75M
Evofem Biosciences	20.18M
International Stem Cell	9.10M
Lyra Therapeutics	398.00K
Eastgate Biotech	137.64K
Halberd	6.94K

Revenue Rankings

Iterum Therapeutics News

4 weeks ago - Iterum files wind-up petition due to limited cash, inability to raise equity - Reuters
4 weeks ago - Iterum Therapeutics Announces Filing of Winding Up Petition - GlobeNewsWire
2 months ago - Iterum Therapeutics Provides Business Update - GlobeNewsWire
5 months ago - Iterum Therapeutics Earnings Call Transcript: Q3 2025 - Transcripts
5 months ago - Iterum Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
6 months ago - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 - GlobeNewsWire
6 months ago - Iterum Therapeutics to Present Data at IDWeek 2025 - GlobeNewsWire
8 months ago - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - GlobeNewsWire

More News